CPA Applauds Senate, House Letters Supporting Solar Trade Case against China
Holding China accountable for its illegal trade practices will allow for the growth of a more diverse, and more secure, solar supply chain, here in the United States.
Biden Administration Action to Increase Section 301 China Tariffs – The Details
This article includes details of products, rate increases, timelines, and the background behind the Biden Administration’s Section 301 Tariff Increase Proposal.
Airbus: State-Owned Success Story and Proof Industrial Policy Can Work
Airbus is the greatest success of industrial policy in modern history. It is the world’s most successful commercial airplane manufacturer, with a global workforce of 121,000 people around the world.
The Case for More Aggressive Tariffs, Exchange Rates, and Monetary Policy
The next president should use every tool to rebuild America’s productivity, industrial base and middle class. And they should ignore the conventional economic textbook view that predicts calamity if those tools are used, especially because these predictions never come true.
USTR Katherine Tai Reiterates New Ideas On Trade In Financial Times Editorial
U.S. Trade Representative Katherine Tai took to the Financial Times this week to re-state her position, and President Biden’s, that from now on, global trade has to benefit the common good.
CPA: China’s Shein Should be Barred from U.S. IPO
Shein’s troubling record of misrepresentations, human rights abuses, and several other concerns should properly exclude the company from being listed on any U.S. exchanges.
Standard Pipe Exporters’ Sourcing Linked to Sanctioned Countries and Duty Circumvention
The standard pipe import surge from the UAE, Thailand, Vietnam, and Oman is particularly concerning as these countries continue to have substantial economic ties with countries considered U.S. geopolitical adversaries.
Attacks on Americas Act Reveals Opponents of WTO Tariff Reform Have No Solutions
CPA has championed the need for the United States to free itself from the Literally America Last shackles of WTO tariff commitments. Most are unaware
FDA Official Laments To Congress That Drug Recall Decisions Rely On Foreign Labs
When drugs are pulled from pharmacy shelves, it’s somewhat of a well-kept secret that it is the pharmaceutical company that voluntarily warns buyers of the potential harm from the defect.
Senate Finance’s Subcommittee on Trade Takes One-Sided Approach to De Minimis Import Rule
The U.S. Senate Finance Subcommittee for International Trade, Customs, and Global Competitiveness took a one-sided view on the de minimis exemption in a hearing on Tuesday, rejecting anything but technocratic changes to the global duty-free rule for small packages priced under $800.
